American Century Companies’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.2M Buy
856,310
+1,084
+0.1% +$29.6K 0.01% 1039
2025
Q4
$23.2M Buy
855,226
+39,666
+5% +$1.04M 0.01% 1096
2025
Q3
$21.1M Buy
815,560
+35,575
+5% +$824K 0.01% 1125
2025
Q2
$15.9M Buy
779,985
+154,664
+25% +$3.01M 0.01% 1190
2025
Q1
$11.3M Buy
625,321
+16,864
+3% +$377K 0.01% 1280
2024
Q4
$15.4M Buy
608,457
+193,093
+46% +$5.25M 0.01% 1174
2024
Q3
$14.1M Sell
415,364
-636
-0.2% -$24.2K 0.01% 1174
2024
Q2
$15.4M Buy
416,000
+233,928
+128% +$8.83M 0.01% 1063
2024
Q1
$7.64M Buy
182,072
+21,021
+13% +$863K ﹤0.01% 1315
2023
Q4
$6.39M Buy
161,051
+191
+0.1% +$5.62K ﹤0.01% 1322
2023
Q3
$4.43M Buy
160,860
+23
+0% +$721 ﹤0.01% 1375
2023
Q2
$5.46M Sell
160,837
-4,891
-3% -$165K ﹤0.01% 1272
2023
Q1
$5.95M Sell
165,728
-32,233
-16% -$1.39M ﹤0.01% 1199
2022
Q4
$8.82M Buy
197,961
+2,399
+1% +$85.6K 0.01% 1018
2022
Q3
$5.5M Sell
195,562
-723
-0.4% -$22.2K ﹤0.01% 1078
2022
Q2
$5.29M Buy
196,285
+13,268
+7% +$385K ﹤0.01% 1099
2022
Q1
$6.23M Sell
183,017
-1,414
-0.8% -$45.2K ﹤0.01% 1050
2021
Q4
$7.13M Buy
+184,431
New +$8.04M ﹤0.01% 975
2016
Q1
Sell
-4,133
Closed -$972K 1305
2015
Q4
$972K Hold
4,133
﹤0.01% 1115
2015
Q3
$653K Buy
4,133
+682
+20% +$193K ﹤0.01% 1182
2015
Q2
$1.31M Sell
3,451
-1,130
-25% -$449K ﹤0.01% 1104
2015
Q1
$1.92M Sell
4,581
-974
-18% -$348K ﹤0.01% 1057
2014
Q4
$1.52M Sell
5,555
-9
-0.2% -$2.24K ﹤0.01% 1132
2014
Q3
$1.08M Buy
5,564
+1,402
+34% +$305K ﹤0.01% 1169
2014
Q2
$1.02M Sell
4,162
-738
-15% -$167K ﹤0.01% 1213
2014
Q1
$1.3M Sell
4,900
-117
-2% -$44.8K ﹤0.01% 1176
2013
Q4
$1.82M Sell
5,017
-13
-0.3% -$5.01K ﹤0.01% 1128
2013
Q3
$2.67M Buy
+5,030
New +$1.72M ﹤0.01% 1054

Other funds holding CLDX